Target intelligence / Profile preview

Sodium-dependent phosphate transporter 1 (PiT-1) (PiT-1)

Target
PiT-1
Molecular classification
Transporter, Solute carrier family 20, Type III sodium-dependent phosphate transporter
01

Overview

Sodium-dependent phosphate transporter 1 (PiT-1), encoded by the SLC20A1 gene, is a transmembrane protein essential for maintaining cellular inorganic phosphate levels by facilitating sodium-coupled phosphate uptake [UniProt: Q06830]. It is ubiquitously expressed and serves as a critical regulator of various physiological processes, including bone mineralization and cell cycle progression [PubMed: 23539153]. In pathological contexts, PiT-1 is a key driver of vascular calcification, particularly in patients with chronic kidney disease, where elevated phosphate levels induce its expression in vascular smooth muscle cells, leading to their transformation into bone-like cells [PubMed: 18632857]. Additionally, PiT-1 has been identified as a receptor for the Gibbon ape leukemia virus, highlighting its diverse biological roles [PubMed: 11053244]. While drugs like foscarnet can inhibit PiT-1 activity, the development of highly selective inhibitors is a focus of current research to treat cardiovascular and metabolic diseases without disrupting systemic mineral balance [PubMed: 30213834]. Its role in promoting tumor cell proliferation also makes it a potential target in oncology [PubMed: 25614016].

Other names
SLC20A1GLVR1Gibbon ape leukemia virus receptor 1Phosphate transporter 1
02

Mechanism of action

Inhibition of sodium-dependent inorganic phosphate transport across the plasma membrane.

03

Biological functions

Inorganic phosphate transportPhosphate homeostasisCell signalingRegulation of cell proliferationVascular smooth muscle cell transdifferentiation
04

Disease associations

Vascular calcificationChronic kidney diseaseHyperphosphatemiaCancerBone mineralization disorders
05

Safety considerations

Systemic phosphate depletion (hypophosphatemia)Impaired bone mineralizationPotential interference with normal cellular signalingInterference with viral entry mechanisms
06

Interacting drugs

Phosphonoformic acid (Foscarnet)

2 more in the full profile.

07

Biomarkers

PiT-1 expression levels in vascular smooth muscle cellsSerum inorganic phosphate concentrationsVascular calcification scores

Beyond the preview

Go deeper on Sodium-dependent phosphate transporter 1 (PiT-1) (PiT-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent phosphate transporter 1 (PiT-1) (PiT-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call